19 studies found for:    15175435 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Efficacy And Safety Of Xeliri + Avastin Followed By Xelox + Avastin Or Reverse Sequence In Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Interventions: Drug: Capecitabine;   Drug: Bevacizumab;   Drug: Oxaliplatin;   Drug: Irinotecan
2 Terminated
Has Results
A Phase II Safety and Tolerability Study of Bevacizumab When Added to Single-agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to Brain
Condition: Breast Cancer
Interventions: Drug: Bevacizumab;   Drug: Docetaxel;   Drug: CPT-11;   Drug: Paclitaxel;   Drug: Vinorelbine Tartrate;   Drug: Gemcitabine
3 Terminated A Randomized, Placebo-controlled, Double-blind Phase II Study Evaluating if Glucophage Can Avoid Liver Injury Due to Chemotherapy Associated Steatosis
Conditions: Colorectal Cancer;   Steatohepatitis
Intervention: Drug: Metformin/Placebo
4 Unknown  Evaluation of Contrast-Enhanced Ultrasound Imaging for the Early Estimate of Bevacizumab Effect on Colorectal Cancer Liver Metastases
Condition: Metastatic Colorectal Cancer
Intervention: Device: real-time contrast-enhanced ultrasound imaging (CEUS)
5 Recruiting Acquisition of Blood and Tumor Tissue Samples From Patients With Gastrointestinal Cancer
Conditions: Gastrointestinal Neoplasms;   Cancer of Gastrointestinal Tract;   Cancer of the Gastrointestinal Tract;   Gastrointestinal Cancer;   Neoplasms, Gastrointestinal
Intervention:
6 Withdrawn A Study of Bevacizumab to Prevent Malignant Ascites
Condition: Malignant Ascites
Intervention: Drug: Bevacizumab
7 Completed Angiogenesis Inhibitors and Hypertension: Clinical Aspects
Condition: Hypertension
Intervention:
8 Completed Trial of Pemetrexed and Bevacizumab for Recurrent Ovarian Primary Peritoneal Carcinoma
Conditions: Ovarian Carcinoma;   Primary Peritoneal Carcinoma
Interventions: Drug: Pemetrexed;   Drug: Bevacizumab
9 Recruiting Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Treatment Combining Cetuximab With FOLFOX or FOLFIRI in RAS and B-RAF WT Tumors
Condition: Metastatic Colorectal Cancer
Interventions: Procedure: Metastases Resection;   Drug: 5-Fluorouracile;   Drug: leucovorin L;   Drug: Oxaliplatin;   Drug: Irinotecan;   Drug: Cetuximab
10 Completed
Has Results
Abraxane and Avastin as Therapy for Patients With Malignant Melanoma, a Phase II Study
Condition: Metastatic Malignant Melanoma
Interventions: Drug: Avastin;   Drug: Abraxane
11 Terminated Pre- and Post-operative FOLFOX Based Therapy for Patients With Colorectal Cancer With Liver Involvement
Conditions: Colorectal Cancer;   Metastases
Interventions: Drug: Cetuximab;   Drug: Bevacizumab;   Drug: Leucovorin;   Drug: Oxaliplatin;   Drug: Fluorouracil
12 Recruiting Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Bevacizumab With FOLFOX or FOLFIRI.
Condition: Metastatic Colorectal Cancer
Interventions: Procedure: Metastases resection;   Drug: Bevacizumab;   Drug: 5 FU (5Fluorouracile);   Drug: Oxaliplatine;   Drug: Irinotecan
13 Active, not recruiting Oxaliplatin, Capecitabine and Avastin for Metastatic Esophagogastric Adenocarcinoma
Conditions: Esophageal Neoplasms;   Stomach Neoplasms;   Neoplasm Metastasis
Intervention: Drug: capecitabine (Xeloda), oxaliplatin and bevacizumab (Avastin)
14 Recruiting Study to Identify Biomarkers of Clinical Response to Aflibercept in Patients With Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Intervention: Drug: aflibercept + FOLFIRI
15 Active, not recruiting Exploration of Circulating VE-cadherin in Metastatic Colorectal Adenocarcinoma Patients Treated With Bevacizumab
Conditions: Colorectal Cancer;   Metastasis
Intervention: Biological: Bevacizumab + blood samples
16 Unknown  Safety Study of Bevacizumab to Treat Women With a History of Breast Cancer and Suffering From Upper Extremity Lymphedema
Condition: Lymphedema
Intervention: Drug: Bevacizumab
17 Completed Preoperative Combined Induction Chemotherapy With Capecitabine, Oxaliplatin, Bevacizumab and Radiotherapy
Condition: Rectal Cancer
Intervention: Drug: preoperative induction chemotherapy in combination with bevacizumab followed by combined radiochemotherapy with capecitabine
18 Completed
Has Results
Bevacizumab for Treatment of Recurrent Respiratory Papillomatosis (RRP)
Condition: Recurrent Respiratory Papillomatosis
Interventions: Drug: Avastin® (bevacizumab);   Drug: Saline
19 Completed Exercise Intervention Study for Early-Stage Breast Cancer Patients Receiving Neoadjuvant Therapy.
Condition: Breast Cancer
Interventions: Behavioral: Exercise Training;   Behavioral: Chemo only

Indicates status has not been verified in more than two years